Global Pre Filled Saline Syringe Market to Generate Lucrative Revenue Prospects for Manufacturers After the End of COVID-19 Crisis and Forecast 2018 – 2028

Pre-Filled Saline Syringe Reduce Medication Errors and Contamination

Increasing medication errors and risk of contamination in multi-dose vials are expected to boost the growth of the pre-filled saline syringes market. Pre-filled syringes offer numerous advantages and are used commonly in flushing of all vascular access devices. They prevent infection outbreaks and cross-contamination due to unit of use dose from large volume bags of normal saline and repetitive usage of multi-dose vials. Pre-filled saline syringes are designed to prevent solution from reentering into non-sterile portion of the syringe and help to reduce contamination. These syringes are manufactured according to ISMP medication labeling and they help to reduce medication errors. Medication error is the failure in the treatment due to under prescribing, irrational and inappropriate prescribing, or over prescribing of the medication. Sometimes, medication errors also occur due to contamination, adulteration, wrong packaging or erroneous adulteration. All the pre-filled saline syringes are single-use devices and are not provided with any kind of preservatives. This attempt is used to save time and money of the end users and they are also incorporated with two sterilization processes, i.e., terminal sterilization and aseptic sterilization. These sterilization processes are to ensure the product safety from contaminations.

Request to Sample report @ https://www.persistencemarketresearch.com/samples/22660

Patient Safety

Patient safety is now receiving well-determined attention to increase the quality of life which increases significant opportunity for the manufacturing companies. Prefilled syringes are preferred over conventional vials, as they facilitate various benefits such as less over-filling, safe and convenient use, which increases the demand for prefilled syringes. Prefilled syringes saline delivery is convenient for patient, who need parenteral administration on daily or weekly basis and long-term treatment. The demand for prefilled syringes is increasing as it is designed in accordance with patient acceptance and compliance. Technological advancements have made injections more user friendly and convenient to perform.  This has motivated patients & physicians to adopt prefilled syringes in chronic illness, and other lifestyle-related diseases. Prefilled syringes are mostly single use, disposable with extra layer of protection, so it is costly and prevents counterfeit. It is difficult to gain access to the primary packaging without destroying the device because of tamper-evident packaging. According to the WHO estimates, about 30% of drugs sold in developing countries, and in some parts of Asia, Africa and Latin America are fraudulent pharmaceuticals.  Packaging technology for prefilled syringe is rapidly evolving with new polymers that are less prone to extractable and leachable and which provide better protection of drugs.

How the Coronavirus Threat has Taken Global Business into Uncharted Waters

Factors Driving the Pre-Filled Saline Syringe Market

The global market for pre-filled saline syringe is driven by their increasing adoption to decrease the cross contamination of medication. Besides, increase in homecare and self-injectable medicines to avoid visits to hospitals has increased the healthcare spending globally and expected to boost the market. According to the OECD Health at a Glance 2017, the healthcare spending in OECD was about US$ 4000 per person, whereas the U.S. spending accounted for almost US$ 10,000 per person. Other factors such as availability of well-developed manufacturing infrastructure and low-cost labor associated with manufacturing of prefilled syringes have shifted the trend of outsourcing empty prefilled syringes manufacturing to in-house prefilled syringes manufacturing. This strategy have enabled the companies to increase their profitability in the market. In June 2013, Roselabs Biosciences opened Rupees 400 cr pre-filled syringes unit in Ahmedabad to manufacture empty PFS.

Pre-Filled Saline Syringe by Product Type

Significant portion of the market has been covered by 3 Syringe type, 5 syringe type and 10 syringe type. 3 and 10 syringe type segments collectively hold a large revenue share in the market. This is due to higher adoption among the end-user segments. Moreover, the awareness towards cross-contamination, medication errors and benefits of pre-filled saline syringes over conventional syringes lead to strong positioning of these segments in the overall market.

Request to View TOC @  https://www.persistencemarketresearch.com/toc/22660

High Penetration in the Hospital Segment

Hospitals and clinics segments pose a strong position in the market due to high penetration of the prefilled syringes due to rising healthcare concerns and changing government regulations to minimize the errors in the treatment. These end-user segments have significant portion of revenue share in the overall market. However, continuing growth of homecare settings to reduce the hospitals stay is expected boost the growth of the pre-filled saline syringe market. Further, rising awareness among the end users to increase the patient compliance is expected to boost the growth of the prefilled saline syringes market.

Regional Market Outlook

Geographically, the global pre-filled saline syringe market is segmented into five key regions viz.  North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa. North America is expected to be a dominant region in the global market due to the high penetration among the customers as well as end users. Europe is expected to hold second large market share in the global pre-filled saline syringe market due to growing awareness.

For in-depth competitive analysis, buy now@ https://www.persistencemarketresearch.com/checkout/22660

Recommended For You

About the Author:

Leave a Reply

Your email address will not be published. Required fields are marked *